cluding the type of rhinitis present , and patient age (refer to Tables 3, 4, and 5).1
itis (PAR)
ate for PRN use in episodic AR because of relatively rapid onset of action ms R
NS for associated ocular symptoms ices are typically better for mixed rhinitis
ce impairment, anticholinergic effects of first-generation antihistamines, second-generation tadine without sedation at recommended doses
priate for very severe nasal symptoms r corticosteroids, which should be discouraged
nsion ntihistamines (with loratadine as usual comparator)
patients who have both conditions
appropriate for PRN use in episodic AR n antihistamines with clinically significant effect on nasal congestion
or vasomotor rhinitis
on ur ongestion
stamines, usually occurs within 12 hours, and may start as early as 3 to hours in some patients RA for SAR and PAR r symptoms of AR lso effective for some nonallergic rhinitis
nstrated when used at recommended doses cur, and nasal septal perforation rarely reported
7 days, full benefit may take weeks ure protects for 4 to 8 hours against allergic response mparison to leukotriene antagonists and antihistamines
estion, but inappropriate for daily use because of the risk for rhinitis medicamentosa nt nasal mucosal edema present
Y
FOR INTERNAL USE ONLY
